SUSCEPTIBILITY OF PLASMODIUM-FALCIPARUM TO QUININE IN-VITRO - EFFECTS OF DRUG CONCENTRATIONS AND TIME OF EXPOSURE

被引:17
作者
MAPABA, E [1 ]
HELLGREN, U [1 ]
LANDBERGLINDGREN, A [1 ]
ROMBO, L [1 ]
机构
[1] KAROLINSKA INST,HUDDINGE UNIV HOSP,TROP PHARMACOL UNIT,S-14186 HUDDINGE,SWEDEN
关键词
MALARIA; PLASMODIUM FALCIPARUM; QUININE IN VITRO;
D O I
10.1016/0035-9203(95)90671-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We have studied the relationship between quinine concentrations ranging from 0.16 to 332 mu mol/L in a blood-medium mixture and the time of exposure (12-168 h) needed for inhibition of Plasmodium falciparum (F32 strain) in continuous culture. When we exposed the parasites for 12 h, only brief inhibition was observed. After 24 h of exposure, parasites were inhibited for 2-3 d at quinine concentrations greater than or equal to 10.4 mu mol/L. With 48 and 72 h of exposure, the inhibition lasted for 6-8 d at concentrations greater than or equal to 1.3 mu mol/L and for 8-11 d at concentrations between 2.6 and 166 mu mol/L. After 96 h of exposure, parasites were inhibited for 11-17 d at concentrations greater than or equal to 0.65 mu mol/L. With 168 h of exposure, parasites were inhibited at all quinine concentrations greater than or equal to 0.65 mu mol/L during 28 d of post-exposure cultivation. After reappearance, parasites multiplied on average 7.6 fold during each parasite schizogony cycle. The calculated parasite elimination rate in the presence of effective concentrations of quinine was 99.7-99.9% per cycle. We conclude that the elimination rate of the parasites is concentration-dependent at low concentrations of quinine in vitro. As soon as a threshold concentration of 0.65-2.6 mu mol/L is attained, only the exposure time determines parasite elimination. These experiments suggest that it might be preferable to reduce each dose rather than the duration of treatment in areas where P. falciparum is susceptible to quinine.
引用
收藏
页码:85 / 89
页数:5
相关论文
共 13 条
[1]  
BJORKMAN A, 1991, B WORLD HEALTH ORGAN, V69, P459
[2]  
BRUCHFELD J, 1991, TROP MED PARASITOL, V42, P153
[3]   REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DETERMINATION OF QUININE IN PLASMA, WHOLE-BLOOD, URINE, AND SAMPLES DRIED ON FILTER-PAPER [J].
ERICSSON, O ;
FRIDEN, M ;
HELLGREN, U ;
GUSTAFSSON, LL .
THERAPEUTIC DRUG MONITORING, 1993, 15 (04) :334-337
[4]   INTRAVENOUS QUININE THERAPY OF HOSPITALIZED CHILDREN WITH PLASMODIUM-FALCIPARUM MALARIA IN KINSHASA, ZAIRE [J].
GREENBERG, AE ;
NGUYENDINH, P ;
DAVACHI, F ;
YEMVULA, B ;
MALANDA, N ;
NZEZA, M ;
WILLIAMS, SB ;
DEZWART, JF ;
NZEZA, M .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1989, 40 (04) :360-364
[5]   STUDIES ON THE ANTIMALARIAL MODE OF ACTION OF QUINOLINE-CONTAINING DRUGS - TIME-DEPENDENCE AND IRREVERSIBILITY OF DRUG-ACTION, AND INTERACTIONS WITH COMPOUNDS THAT ALTER THE FUNCTION OF THE PARASITES FOOD VACUOLE [J].
KRUGLIAK, M ;
GINSBURG, H .
LIFE SCIENCES, 1991, 49 (17) :1213-1219
[6]  
KYLE DE, 1992, 13 C TROP MED MAL PA, V2, P50
[7]  
MBUDI PK, 1989, ANN SOC BELG MED TR, V69, P25
[8]   PLASMODIUM-FALCIPARUM - INVITRO STUDIES OF THE PHARMACODYNAMIC PROPERTIES OF DRUGS USED FOR THE TREATMENT OF SEVERE MALARIA [J].
TERKUILE, F ;
WHITE, NJ ;
HOLLOWAY, P ;
PASVOL, G ;
KRISHNA, S .
EXPERIMENTAL PARASITOLOGY, 1993, 76 (01) :85-95
[9]  
TRAGER W, 1976, SCIENCE, V199, P673
[10]   FALCIPARUM-MALARIA - DIFFERENTIAL-EFFECTS OF ANTIMALARIAL-DRUGS ON EX-VIVO PARASITE VIABILITY DURING THE CRITICAL EARLY PHASE OF THERAPY [J].
WATKINS, WM ;
WOODROW, C ;
MARSH, K .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 49 (01) :106-112